Evidence map›Paper›PMID 38939897›Full record

ArticleJournal of extracellular biology2024

ISG15 mediates the function of extracellular vesicles in promoting ovarian cancer progression and metastasis.

Kalpana Deepa Priya Dorayappan, Vincent Wagner, Dongju Park, Meghan M Newcomer, Michelle D S Lightfoot, Deepika Kalaiyarasan, Takahiko Sakaue, Wafa Khadraoui, Lianbo Yu, Qi-En Wang and 5 more

Erratum issuedAbstract read
In one paragraph

Article in Journal of extracellular biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
  5. ISGylation: is our genome yearning for such a modification?Acta biochimica et biophysica Sinica · 2025
    Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors.

Kalpana Deepa Priya DorayappanDivision of Gynecologic Oncology, Department of Obstetrics and Gynecology Comprehensive Cancer Center, The Ohio State University Wexner Medical Center Columbus Ohio USA.
Vincent WagnerDivision of Gynecologic Oncology, Department of Obstetrics and Gynecology Comprehensive Cancer Center, The Ohio State University Wexner Medical Center Columbus Ohio USA.
Dongju ParkMolecular Genetics, Comprehensive Cancer Center The Ohio State University Wexner Medical Center Columbus Ohio USA.
Meghan M NewcomerDepartment of Anatomy, School of Medicine Case Western Reserve University Cleveland Ohio USA.
Michelle D S LightfootDivision of Gynecologic Oncology, Department of Obstetrics and Gynecology NYU Langone Health/Perlmutter Cancer Center New York New York USA.
Deepika KalaiyarasanDivision of Gynecologic Oncology, Department of Obstetrics and Gynecology Comprehensive Cancer Center, The Ohio State University Wexner Medical Center Columbus Ohio USA.
Takahiko SakaueDivision of Gynecologic Oncology, Department of Obstetrics and Gynecology Comprehensive Cancer Center, The Ohio State University Wexner Medical Center Columbus Ohio USA.
Wafa KhadraouiDivision of Gynecologic Oncology, Department of Obstetrics and Gynecology Comprehensive Cancer Center, The Ohio State University Wexner Medical Center Columbus Ohio USA.
Lianbo YuDepartment of Biomedical Informatics The Ohio State University Wexner Medical Center Columbus Ohio USA.
Qi-En WangDepartment of Radiation Oncology The Ohio State University Columbus Ohio USA.
G Larry MaxwellInova Women's Service Line and the Inova Schar Cancer Institute Falls Church Virginia USA.
David O'MalleyDivision of Gynecologic Oncology, Department of Obstetrics and Gynecology Comprehensive Cancer Center, The Ohio State University Wexner Medical Center Columbus Ohio USA.
Raphael E PollockDivision of Surgical Oncology, The James Comprehensive Cancer Center Ohio State University Columbus Ohio USA.
David E CohnDivision of Gynecologic Oncology, Department of Obstetrics and Gynecology Comprehensive Cancer Center, The Ohio State University Wexner Medical Center Columbus Ohio USA.
Karuppaiyah SelvendiranDivision of Gynecologic Oncology, Department of Obstetrics and Gynecology Comprehensive Cancer Center, The Ohio State University Wexner Medical Center Columbus Ohio USA.ORCID https://orcid.org/0000-0002-8016-9134

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The interferon stimulated gene 15 (ISG15), a ubiquitin like protein and its conjugates have been implicated in various human malignancies. However, its role in ovarian cancer progression and metastasis is largely unknown. In high grade serous ovarian cancer (HGSOC), ascites is the major contributor to peritoneal metastasis. In this study, we identified significantly elevated ISG15 protein expression in HGSOC patient ascites, ascites derived primary ovarian cancer cells (POCCs), POCC small extracellular vesicles (sEVs) as well as metastatic tissue. Our results demonstrates that ISG15 increases exocytosis in ascites-derived POCCs by decreasing the endosome-lysosomal fusion, indicating a key role in sEV secretion. Further, knockdown (KD) of ISG15 resulted in a significant decrease in vesicles secretion from HGSOC cells and

Indexed as

ascitesextracellular vesiclesISG15ISGylationmetastasis and biomarkerovarian cancer

Identifiers

PMID38939897
PMCPMC11080709

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.